首页> 外文期刊>Journal of Drug Delivery and Therapeutics >Formulation, development and evaluation of Microsponge loaded Topical Gel of Nystatin
【24h】

Formulation, development and evaluation of Microsponge loaded Topical Gel of Nystatin

机译:制霉菌素微海绵负载局部用凝胶的配制,开发和评价

获取原文
           

摘要

Nystatin containing microsponge as active constituent (API) in different formulations by changing the proportions of drug (Nystatin), polymer (ethyl cellulose), emulsifier (Poly vinyl alcohol) were obtained successfully using quasi-emulsion solvent diffusion method. These formulations were studied for particle size and physical characterization. Scanning electron microscopy (SEM) images showed the microsponges porous and spherical in shape. The physical characterization showed that microsponge formulation coded by P6 showed a better loading efficiency and production yield. This microsponge formulation was prepared as gel in carbopol and studied for pH, viscosity, spreadability, drug content, in-vitro release. The microsponge formulation gel, F3 showed viscosity3465.84cps,spreadability of 26.22g cm/s and drug content of 89.65%. The nystatin microsponge gel formulations showed an appropriate drug release profile. F3 released 81.03% of drug at 12 hours.
机译:通过改变药物(制霉菌素)的比例,在不同的配方中以微海绵为活性成分(API)制霉菌素,采用准乳液溶剂扩散法成功地获得了聚合物(乙基纤维素),乳化剂(聚乙烯醇)。研究了这些制剂的粒度和物理特性。扫描电子显微镜(SEM)图像显示微海绵呈多孔和球形。物理表征表明,由P6编码的微海绵制剂表现出更好的负载效率和生产产率。将该微海绵制剂制备为在卡波姆中的凝胶,并研究其pH值,粘度,铺展性,药物含量和体外释放。微海绵制剂凝胶F3的粘度为3465.84cps,扩展性为26.22g cm / s,药物含量为89.65%。制霉菌素微海绵凝胶制剂显示出适当的药物释放曲线。 F3在12小时内释放了81.03%的药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号